Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 1/2010

01-02-2010 | Brief Communication

Utility of the twelve-item World Health Organization Disability Assessment Schedule II (WHO-DAS II) for discriminating depression “caseness” and severity in Spanish primary care patients

Auteurs: Juan V. Luciano, José L. Ayuso-Mateos, Ana Fernandez, Jaume Aguado, Antoni Serrano-Blanco, Miquel Roca, Josep M. Haro

Gepubliceerd in: Quality of Life Research | Uitgave 1/2010

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The 12-item WHO-DAS II was developed to assess the activity limitations and participation restrictions experienced by individuals irrespective of medical diagnosis. In this paper we examine the known-groups’ validity of the instrument by evaluating its ability to discriminate between patients with/without major depression, patients with depression with/without medical comorbidity, and patients with depression with different depression severity.

Method

The participants were 3,615 PC patients from 17 regions of Spain, with a first-time diagnosis of major depressive episode according to the general practitioner. The 12-item WHO-DAS II, the PHQ-9, and a chronic medical conditions checklist were administered during the consultation.

Results

The statistical analyses indicated that the 12-item WHO-DAS II was able to discriminate between patients with/without depression and between those with different depression severity. The ROC analysis revealed that with a cutoff score ≥50, the instrument correctly classified 70.4% of the sample (area under the ROC curve = .76; sensitivity = 71.4%; specificity = 67.6%).

Conclusions

Overall, our results support the discriminant validity of the 12-item WHO-DAS II for major depression, being quite recommendable its use in epidemiological research.
vorige artikel The challenge of validating SF-12 for its use with community-dwelling elderly in Israel
volgende artikel The Functional Living Index-Cancer: estimating its reliability based on clinical trial data
Literatuur
1.
Mathers, C. D., & Loncar, D. (2005). Updated projections of global mortality and burden of disease, 2002–2030: data sources, methods and results. Geneva: World Health Organization (Evidence and Information for Policy Working Paper).
2.
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association, 289, 3095–3105.CrossRefPubMed
3.
Üstün, T. B., Ayuso-Mateos, J. L., Chatterji, S., Mathers, C., & Murray, C. J. (2004). Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 184, 386–392.CrossRefPubMed
4.
Ormel, J., Petukhova, M., Chatterji, S., Aguilar-Gaxiola, S., Alonso, J., Angermeyer, M. C., et al. (2008). Disability and treatment of specific mental and physical disorders across the world. British Journal of Psychiatry, 192, 368–375.CrossRefPubMed
5.
Wittchen, H. U., & Pittrow, D. (2002). Prevalence, recognition and management of depression in primary care in Germany: The depression 2000 study. Human Psychopharmacology, 17(Suppl. 1), S1–S11.CrossRefPubMed
6.
Ansseau, M., Fischler, B., Dierick, M., Albert, A., Leyman, S., & Mignon, A. (2007). Socioeconomic correlates of generalized anxiety disorder and major depression in primary care: the GADIS II study (generalized anxiety and depression impact survey II). Depression and Anxiety, 26, 1–8.
7.
Serrano-Blanco, A., Palao, D.J., Luciano, J.V., Pinto-Meza, A., Luján, L., Fernández, A., Roura, P., Bertsch, J., Mercader, M., Haro, J.M. (2009). Prevalence of mental disorders in primary care: Results from the diagnosis and treatment of mental disorders in primary care study (DASMAP). Social Psychiatry and Psychiatric Epidemiology. May 19. [Epub ahead of print].
8.
Cepoiu, M., McCusker, J., Cole, M. G., Sewitch, M., Belzile, E., & Ciampi, A. (2007). Recognition of depression by non-psychiatric physicians––A systematic literature review and meta-analysis. Journal of General Internal Medicine, 23, 25–36.CrossRefPubMed
9.
Lecrubier, Y. (2007). Widespread underrecognition and undertreatment of anxiety and mood disorders: Results from 3 European studies. Journal of Clinical Psychiatry, 68(Suppl 2), 36–41.PubMed
10.
Collings, S. (2005). Disability and the detection of mental disorder in primary care. Social Psychiatry and Psychiatric Epidemiology, 40, 994–1002. The MaGPIe Research Group.CrossRefPubMed
11.
Gilbody, S., Sheldon, T., & House, A. (2008). Screening and case-finding instruments for depression: A meta-analysis. Canadian Medical Association Journal, 178, 997–1003.CrossRefPubMed
12.
13.
14.
Chwastiak, L. A., & Von Korff, M. (2003). Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting. Journal of Clinical Epidemiology, 56, 507–514.CrossRefPubMed
15.
Pösl, M., Cieza, A., & Stucki, G. (2007). Psychometric properties of the WHO-DAS II in rehabilitation patients. Quality of Life Research, 16, 1521–1531.CrossRefPubMed
16.
Luciano, J.V., Ayuso-Mateos, J.L., Fernández A., Serrano-Blanco, A., Roca, M., Haro, J.M. (2009). Psychometric properties of the twelve item World Health Organization Disability Assessment Schedule II (WHO-DAS II) in Spanish primary care patients with a first major depressive episode. Journal of Affective Disorders. May 21. [Epub ahead of print].
17.
Vázquez-Barquero, J. L., Vázquez Bourgón, E., Herrera Saiz, J., Uriarte, M., Morales, F., Gaite, L., et al. (2000). Spanish version of the new World Health Organization Disability Assessment Schedule II (WHO-DAS-II): Initial phase of development and pilot study. Cantabria disability work group. Actas Españolas de Psiquiatria, 28, 77–87.PubMed
18.
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606–613.CrossRefPubMed
19.
Diez-Quevedo, C., Rangil, T., Sanchez-Planell, L., Kroenke, K., & Spitzer, R. L. (2001). Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish impatients. Psychosomatic Medicine, 63, 679–686.PubMed
20.
Association, American. Psychiatric. (2000). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
21.
Baron, M., Schieir, O., Hudson, M., Steele, R., Kolahi, S., Berkson, L., et al. (2008). The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis. Arthritis and Rheumatism, 59, 382–390.CrossRefPubMed
22.
Löwe, B., Spitzer, R. L., Grafe, K., Kroenke, K., Quenter, A., Zipfel, S., et al. (2004). Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physician’s diagnoses. Journal of Affective Disorders, 78, 131–140.CrossRefPubMed
23.
Luciano, J.V., Bertsch, J., Salvador-Carulla, S., Fernandez, A., Pinto-Meza, A., Haro, J.M., Palao, D.J., Serrano-Blanco, A. Factor structure, internal consistency and construct validity of the Sheehan disability scale in a spanish primary care sample. Journal of Evaluation in Clinical Practice (In press).
24.
Leon, A. C., Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997). Assessing psychiatric impairment in primary care with the Sheehan disability scale. International Journal of Psychiatry in Medicine, 27, 93–105.PubMed
25.
Rabe-Hesketh, S., & Skrondal, A. (2008). Classical latent variable models for medical research. Statistical Methods in Medical Research, 17, 5–32.CrossRefPubMed
Metagegevens
Titel
Utility of the twelve-item World Health Organization Disability Assessment Schedule II (WHO-DAS II) for discriminating depression “caseness” and severity in Spanish primary care patients
Auteurs
Juan V. Luciano
José L. Ayuso-Mateos
Ana Fernandez
Jaume Aguado
Antoni Serrano-Blanco
Miquel Roca
Josep M. Haro
Publicatiedatum
01-02-2010
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 1/2010
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9566-z

Andere artikelen Uitgave 1/2010

Quality of Life Research 1/2010 Naar de uitgave

OriginalPaper

Operationalization of the SAMHSA model of recovery: a quality of life perspective

OriginalPaper

Change in health-related quality of life as a predictor of mortality in the older adults

OriginalPaper

Women’s perceptions of their husband’s drinking behavior as a risk factor of their health-related quality of life in the postpartum period

OriginalPaper

Health status utilities and the impact of pressure ulcers in long-term care residents in Ontario

OriginalPaper

The analysis of longitudinal quality of life measures with informative drop-out: a pattern mixture approach

Brief Communication

The challenge of validating SF-12 for its use with community-dwelling elderly in Israel